Larry Michael Mertz's Insider Trades & SAST Disclosures
Larry Michael Mertz's most recent trade in Accelerate Diagnostics Inc was a trade of 120,000 Employee Restricted Stock Units done . Disclosure was reported to the exchange on May 29, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Larry Michael Mertz.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Accelerate Diagnostics Inc | Larry Michael Mertz | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 120,000 | 120,000 | - | - | Employee Restricted Stock Units | |
| Accelerate Diagnostics Inc | Larry Michael Mertz | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2024 | 1,000 | 0 | - | - | Employee Restricted Stock Units | |
| Accelerate Diagnostics Inc | Larry Michael Mertz | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2024 | 1,000 | 82,106 (0%) | 0% | 0 | Common Stock | |
| Accelerate Diagnostics Inc | Larry Michael Mertz | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2024 | 283 | 0 | - | - | Employee Restricted Stock Units | |
| Accelerate Diagnostics Inc | Larry Michael Mertz | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2024 | 283 | 82,114 (0%) | 0% | 0 | Common Stock | |
| Accelerate Diagnostics Inc | Larry Michael Mertz | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 0.88 per share. | 20 May 2024 | 275 | 81,831 (0%) | 0% | 0.9 | 242 | Common Stock |
| Accelerate Diagnostics Inc | Larry Michael Mertz | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 0.88 per share. | 20 May 2024 | 86 | 82,028 (0%) | 0% | 0.9 | 76 | Common Stock |
| Accelerate Diagnostics Inc | Larry Michael Mertz | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2024 | 40,633 | 95,090 (0%) | 0% | 0 | Common Stock | |
| Accelerate Diagnostics Inc | Larry Michael Mertz | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2024 | 40,633 | 0 | - | - | Employee Restricted Stock Units | |
| Accelerate Diagnostics Inc | Larry Michael Mertz | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 0.87 per share. | 09 Apr 2024 | 13,984 | 81,106 (0%) | 0% | 0.9 | 12,166 | Common Stock |
| Accelerate Diagnostics Inc | Larry Michael Mertz | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Apr 2024 | 2,866 | 55,435 (0%) | 0% | 0 | Common Stock | |
| Accelerate Diagnostics Inc | Larry Michael Mertz | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Apr 2024 | 2,866 | 4,298 | - | - | Employee Restricted Stock Units | |
| Accelerate Diagnostics Inc | Larry Michael Mertz | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 0.88 per share. | 04 Apr 2024 | 978 | 54,457 (0%) | 0% | 0.9 | 861 | Common Stock |
| Accelerate Diagnostics Inc | Larry Michael Mertz | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2024 | 40,633 | 40,633 | - | - | Employee Restricted Stock Units | |
| Accelerate Diagnostics Inc | Larry Michael Mertz | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2023 | 663,537 | 663,537 | - | - | Employee Restricted Stock Units | |
| Accelerate Diagnostics Inc | Larry Michael Mertz | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2023 | 10,000 | 526,339 (0%) | 0% | 0 | Common Stock | |
| Accelerate Diagnostics Inc | Larry Michael Mertz | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2023 | 10,000 | 10,000 | - | - | Employee Restricted Stock Units | |
| Accelerate Diagnostics Inc | Larry Michael Mertz | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2023 | 2,836 | 2,835 | - | - | Employee Restricted Stock Units | |
| Accelerate Diagnostics Inc | Larry Michael Mertz | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2023 | 2,836 | 526,464 (0%) | 0% | 0 | Common Stock | |
| Accelerate Diagnostics Inc | Larry Michael Mertz | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 0.72 per share. | 22 May 2023 | 2,711 | 523,628 (0%) | 0% | 0.7 | 1,952 | Common Stock |
| Accelerate Diagnostics Inc | Larry Michael Mertz | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 0.72 per share. | 22 May 2023 | 769 | 525,695 (0%) | 0% | 0.7 | 554 | Common Stock |
| Accelerate Diagnostics Inc | Larry Michael Mertz | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2023 | 116,329 | 549,740 (1%) | 0% | 0 | Common Stock | |
| Accelerate Diagnostics Inc | Larry Michael Mertz | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2023 | 116,329 | 0 | - | - | Employee Restricted Stock Units | |
| Accelerate Diagnostics Inc | Larry Michael Mertz | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 0.49 per share. | 02 Mar 2023 | 33,401 | 516,339 (0%) | 0% | 0.5 | 16,366 | Common Stock |
| Accelerate Diagnostics Inc | Larry Michael Mertz | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 116,329 | 116,329 | - | - | Employee Restricted Stock Units | |
| Accelerate Diagnostics Inc | Larry Michael Mertz | Chief Technology Officer | Purchase of securities on an exchange or from another person at price $ 1.60 per share. | 30 Aug 2022 | 50,000 | 433,411 (0%) | 0% | 1.6 | 80,000 | Common Stock |
| Accelerate Diagnostics Inc | Larry Michael Mertz | Chief Technology Officer | Purchase of securities on an exchange or from another person at price $ 1.35 per share. | 22 Aug 2022 | 51,749 | 383,411 (0%) | 0% | 1.3 | 69,861 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges